Henry Schein, Inc. (NASDAQ:HSIC) Given Average Recommendation of “Moderate Buy” by Brokerages

Henry Schein, Inc. (NASDAQ:HSIC) has been given a consensus recommendation of “Moderate Buy” by the eleven brokerages that are currently covering the stock, Marketbeat.com reports. Five investment analysts have rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company. The average 12 month price target among brokers that have issued a report on the stock in the last year is $78.89.

Several equities analysts recently weighed in on HSIC shares. JPMorgan Chase & Co. cut their price target on Henry Schein from $88.00 to $80.00 and set an “overweight” rating for the company in a research note on Monday, August 12th. Barrington Research restated an “outperform” rating and issued a $82.00 price target on shares of Henry Schein in a research note on Wednesday, November 6th. Evercore ISI lifted their price target on Henry Schein from $70.00 to $74.00 and gave the company an “in-line” rating in a research note on Tuesday, October 8th. StockNews.com upgraded Henry Schein from a “sell” rating to a “hold” rating in a research note on Thursday, November 7th. Finally, Robert W. Baird cut their price objective on Henry Schein from $92.00 to $82.00 and set an “outperform” rating for the company in a research note on Wednesday, August 7th.

Henry Schein Stock Performance

NASDAQ HSIC opened at $73.91 on Friday. The stock has a 50-day simple moving average of $70.68 and a two-hundred day simple moving average of $69.69. The firm has a market capitalization of $9.21 billion, a P/E ratio of 30.41, a PEG ratio of 2.15 and a beta of 0.87. Henry Schein has a fifty-two week low of $63.67 and a fifty-two week high of $82.63. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings results on Tuesday, November 5th. The company reported $1.22 earnings per share for the quarter, beating the consensus estimate of $1.17 by $0.05. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The firm had revenue of $3.17 billion during the quarter, compared to analyst estimates of $3.24 billion. During the same quarter in the previous year, the business earned $1.32 EPS. Henry Schein’s revenue for the quarter was up .4% compared to the same quarter last year. On average, equities analysts forecast that Henry Schein will post 4.78 earnings per share for the current year.

Insider Activity at Henry Schein

In related news, SVP Lorelei Mcglynn sold 21,035 shares of the company’s stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $69.30, for a total value of $1,457,725.50. Following the transaction, the senior vice president now directly owns 71,833 shares in the company, valued at approximately $4,978,026.90. This represents a 22.65 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, COO Michael S. Ettinger sold 12,240 shares of the company’s stock in a transaction that occurred on Monday, November 18th. The shares were sold at an average price of $75.00, for a total value of $918,000.00. Following the completion of the transaction, the chief operating officer now owns 87,706 shares in the company, valued at $6,577,950. This represents a 12.25 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.14% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in HSIC. Swedbank AB acquired a new position in Henry Schein in the first quarter valued at approximately $215,998,000. ING Groep NV purchased a new stake in Henry Schein in the third quarter valued at approximately $63,226,000. Holocene Advisors LP purchased a new stake in Henry Schein in the third quarter valued at approximately $58,319,000. Thompson Siegel & Walmsley LLC purchased a new stake in Henry Schein in the second quarter valued at approximately $46,683,000. Finally, Healthcare of Ontario Pension Plan Trust Fund purchased a new stake in Henry Schein in the third quarter valued at approximately $43,740,000. 96.62% of the stock is currently owned by institutional investors and hedge funds.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.